VANCOUVER, BC--(Marketwired - January 23, 2017) - On Tuesday, Jan. 24, the Fraser Institute will release a new study examining intellectual property rights and pharmaceuticals in Canada.
Intellectual Property Rights Protection and the Biopharmaceutical Industry: How Canada Measures Up spotlights pharmaceutical investments and patent protections in Canada and how they compare to other countries around the world.
A news release with additional information will be issued via Marketwired on Jan. 24 at 5:00 a.m. (Eastern).
Follow the Fraser Institute on Twitter | Like us on Facebook
The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org
Contact Information:
MEDIA CONTACTS:
Kristina Lybecker, Senior Fellow
Fraser Institute
To arrange media interviews or for more information, please contact:
Bryn Weese
Media Relations Specialist, Fraser Institute
(604) 688-0221 ext. 589
bryn.weese@fraserinstitute.org